Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Joseph Vinetz
University of California, San Diego, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
LeptoX, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Vinetz is a co-founder and consultant of LeptoX, Inc. He holds (b)(4) equity valued at (b)(4) combined with spouse’s interest. The mission of the company is to produce leptospirosis vaccines and diagnostics. The company plans to license the University IP of which Dr. Vinetz is the inventor. The project is to develop and validate tools for preventing the transmission of Leptospirosis based on detection of Leptospira in environmental sources.
Predicting Risk of Human Leptospiros by Environmental Surveillance
Leptospirosis is a globally important infectious disease, affecting people in industrialized and developing countries alike. The goal of this project is to develop and validate tools for preventing the transmission of this disease based on detection of the causative bacteria, Leptospira, in environmental sources. The impact of this project is broad, and will underlie new strategies to prevent leptospirosis among affected populations including the underserved poor as Well as military and other occupations deployed to leptospirosis-endemic zones.
Filed on March 02, 2018.
Tell us what you know about Joseph Vinetz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Joseph Vinetz filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Joseph Vinetz | University of California, San Diego | Conflict of Interest | LeptoX, Inc. | $0 - $4,999 |
Joseph Vinetz | Yale University | Conflict of Interest | LeptoX, Inc. | Value cannot be readily determined |
Joseph Vinetz | University of California, San Diego | Conflict of Interest | GlimmerDX, LLC | Value cannot be readily determined |
Joseph Vinetz | University of California, San Diego | Conflict of Interest | GlimmerDX, LLC | Value cannot be readily determined |
Joseph Vinetz | University of California, San Diego | Conflict of Interest | GlimmerDX, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.